MedPath

Clinical trial of additional effects of lactic acid bacteria metabolites A6 for diabetes patients

Not Applicable
Conditions
Diabetes
Registration Number
JPRN-UMIN000049382
Lead Sponsor
KOEI SCIENCE LABORATORY Co., Ltd.
Brief Summary

The rate of effect was significantly higher in the high dose group compared to the low dose group. In both groups, fasting blood glucose and HbA1c levels were significantly reduced after the test compared to before the test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Those with infectious diseases 2. Patients undergoing dialysis treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath